Evidence map›Paper›PMID 39571936›Full record

ArticleInternational journal of psychophysiology : official journal of the International Organization of Psychophysiology2025

Biomarker and neuropsychological correlates of the N400 event-related potential in Alzheimer's disease.

Allie R Geiger, Matthew J Euler, Jasmin E Guevara, Julia Vehar, Jace B King, Kevin Duff, John M Hoffman

Abstract read
In one paragraph

Article in International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allie R GeigerDepartment of Psychology, University of Utah, 380 S 1530 E BEH S 502, Salt Lake City, UT 84112, United States of America. Electronic address: allie.geiger@psych.utah.edu.
Matthew J EulerDepartment of Psychology, University of Utah, 380 S 1530 E BEH S 502, Salt Lake City, UT 84112, United States of America.
Jasmin E GuevaraDepartment of Psychology, University of Utah, 380 S 1530 E BEH S 502, Salt Lake City, UT 84112, United States of America.
Julia VeharDepartment of Psychology, University of Utah, 380 S 1530 E BEH S 502, Salt Lake City, UT 84112, United States of America.
Jace B KingDepartment of Radiology and Imaging Sciences, School of Medicine, University of Utah, 30 N 1900 E, Salt Lake City, UT, United States of America.
Kevin DuffSchool of Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, United States of America.
John M HoffmanDepartment of Radiology and Imaging Sciences, School of Medicine, University of Utah, 30 N 1900 E, Salt Lake City, UT, United States of America; Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr., Salt Lake City, UT 84112, United States of America.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Allison Lindauer · 2020 to 2026
$28.6M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Enriching clinical trials requiring amyloid positivity with practice effectsR01AG055428 · NIA · UNIVERSITY OF UTAH · PI DUFF, KEVIN M, HOFFMAN, JOHN M · 2017 to 2021
$3.6M
Novel metrics of brain dynamics in Alzheimer’s diseaseK01AG075166 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jace Bradford King · 2022 to 2026
$651k
Task-related EEG activation as a biomarker for early Alzheimer's DiseaseR03AG063044 · NIA · UNIVERSITY OF UTAH · PI EULER, MATTHEW · 2019 to 2020
$305k
NCATS NIH HHS UM1 TR004409NIA NIH HHS K01 AG075166NIA NIH HHS P30 AG066518NIA NIH HHS R01 AG055428NIA NIH HHS R03 AG063044
6 · The paper itself

Abstract

objectiveThe current study sought to characterize the relationship of the N400 (N4) effect event-related potential to Alzheimer's disease (AD) biomarkers and broader cognition in older adults on the late-life cognitive continuum.

methodParticipants who were cognitively intact (n = 43), or had amnestic mild cognitive impairment (MCI; n = 19), or mild AD (n = 12), completed a word-pair judgement task during concurrent EEG recording to elicit the N400. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and biomarker data (PET-imaged beta-amyloid (aβ) deposition, apolipoprotein-E ε4 (APOE4) allele status, hippocampal volumes) were collected as part of a larger study.

resultsThe AD group had slower response times and poorer accuracy on the word-pair judgement task than the intact group. The N4 effect was smaller and occurred later in AD relative to intact participants. MCI participants' values were intermediate. N4 effect amplitudes were not associated with RBANS scores but were positively associated with aβ deposition. Conversely, poorer performance across most RBANS Indexes and the Total score was associated with longer N4 latencies. There was also a negative association between hippocampal volumes and the N4 latency and a positive association between aβ deposition and latency. Finally, the latency of the N4 independently predicted variance in RBANS Total scores, above and beyond aβ deposition, hippocampal volumes, and APOE4 allele status.

conclusionsThese findings support the relevance of the N4 effect in individuals along the late-life cognitive continuum, and motivate future studies into its potential as a longitudinal predictor in AD.

Indexed as

Alzheimer DiseaseCognitive DysfunctionElectroencephalographyEvoked PotentialsAgedAged, 80 and overAmyloid beta-PeptidesApolipoprotein E4BiomarkersFemaleHippocampusHumansMaleNeuropsychological TestsPositron-Emission TomographyAmyloid beta-PeptidesApolipoprotein E4BiomarkersAlzheimer's diseaseBeta-amyloidEEGERPsNeuropsychology

Identifiers

PMID39571936
PMCPMC11700776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.